{
    "clinical_study": {
        "@rank": "52089", 
        "arm_group": [
            {
                "arm_group_label": "Saccharomyces boulardii", 
                "arm_group_type": "Experimental", 
                "description": "FLORATIL\u00ae. Saccharomyces boulardii 200 mg sachet. One sachet orally, BID, for 5 days."
            }, 
            {
                "arm_group_label": "Probiotics combination", 
                "arm_group_type": "Experimental", 
                "description": "LACTIPAN\u00ae. Probiotics combination sachet. One sachet orally, BID, for 5 days. Lactobacillus acidophilus............. 1.00 x 109 cfu Lactobacillus casei........................ 1.00 x 109 cfu Lactobacillus rhamnosus............. 4.40 x 108 cfu Lactobacillus plantarum............... 1.76 x 108 cfu Bifidobacterium infantis................ 2.76 x 107 cfu Streptococcus thermophillus....... 6.66 x 105 cfu"
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Placebo sachet. One sachet orally, BID, for 5 days."
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine which of two different preparations of probiotics\n      is effective in the treatment of acute viral diarrhoea in children."
        }, 
        "brief_title": "Efficacy of Two Probiotic Preparations in Children With Acute Diarrhoea", 
        "completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Gastroenteritis", 
        "condition_browse": {
            "mesh_term": [
                "Diarrhea", 
                "Gastroenteritis"
            ]
        }, 
        "detailed_description": {
            "textblock": "Children and infants, aged 1 month to 5 years, with acute diarrhoea, will be randomised to\n      receive either saccharomyces boulardii, a combination probiotic (Lactobacillus acidophilus,\n      Lactobacillus casei, Lactobacillus rhamnosus, Lactobacillus plantarum, Bifidobacterium\n      infantis, Streptococcus thermophillus) or placebo, to determine if one shortens the duration\n      of diarrhoea."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Clinical diagnosis of acute viral gastroenteritis\n\n        Exclusion Criteria:\n\n          -  Moderate or severe dehydration\n\n          -  Malnutrition\n\n          -  Immunodeficiencies\n\n          -  Sepsis or bacterial infection\n\n          -  Previous use of antibiotics, antidiarrheal drugs, or probiotics, in the last four\n             weeks.\n\n          -  Hospitalisation\n\n          -  No phone number\n\n          -  Illiteracy"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "5 Years", 
            "minimum_age": "1 Month"
        }, 
        "enrollment": {
            "#text": "150", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 4, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02080130", 
            "org_study_id": "HPS-03"
        }, 
        "intervention": [
            {
                "arm_group_label": "Saccharomyces boulardii", 
                "description": "FLORATIL\u00ae. Saccharomyces boulardii 200 mg sachet. One sachet orally, BID, for 5 days.", 
                "intervention_name": "Saccharomyces boulardii", 
                "intervention_type": "Dietary Supplement"
            }, 
            {
                "arm_group_label": "Probiotics combination", 
                "description": "LACTIPAN\u00ae. Probiotics combination sachet. One sachet orally, BID, for 5 days. Lactobacillus acidophilus............. 1.00 x 109 cfu Lactobacillus casei........................ 1.00 x 109 cfu Lactobacillus rhamnosus............. 4.40 x 108 cfu Lactobacillus plantarum............... 1.76 x 108 cfu Bifidobacterium infantis................ 2.76 x 107 cfu Streptococcus thermophillus....... 6.66 x 105 cfu", 
                "intervention_name": "Probiotics combination", 
                "intervention_type": "Dietary Supplement"
            }, 
            {
                "arm_group_label": "Placebo", 
                "description": "Placebo", 
                "intervention_name": "Placebo", 
                "intervention_type": "Other"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Gastroenteritis", 
            "diarrhea"
        ], 
        "lastchanged_date": "March 5, 2014", 
        "location": {
            "contact": {
                "email": "giordano@sinestetoscopio.com", 
                "last_name": "Giordano P\u00e9rez-Gaxiola, MD", 
                "phone": "+52 (667) 7139004", 
                "phone_ext": "252"
            }, 
            "facility": {
                "address": {
                    "city": "Culiacan", 
                    "country": "Mexico", 
                    "state": "Sinaloa", 
                    "zip": "80200"
                }, 
                "name": "Sinaloa Pediatric Hospital"
            }, 
            "investigator": {
                "last_name": "Giordano P\u00e9rez-Gaxiola, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Mexico"
        }, 
        "number_of_arms": "3", 
        "official_title": "Efficacy of Two Probiotic Preparations in Children With Acute Viral Diarrhoea, Randomised Controlled Trial", 
        "overall_contact": {
            "email": "giordano@sinestetoscopio.com", 
            "last_name": "Giordano P\u00e9rez-Gaxiola, MD", 
            "phone": "+52 (667) 7139004", 
            "phone_ext": "252"
        }, 
        "overall_official": {
            "affiliation": "Sinaloa Pediatric Hospital", 
            "last_name": "Giordano P\u00e9rez-Gaxiola, MD", 
            "role": "Study Chair"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Mexico: Secretaria de Salud", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "October 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Duration of diarrhoea in hours", 
            "safety_issue": "No", 
            "time_frame": "Up to 7 days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02080130"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Sinaloa Pediatric Hospital", 
            "investigator_full_name": "Giordano Perez Gaxiola", 
            "investigator_title": "Pediatrician", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "Percentage of children requiring hospitalisation", 
                "safety_issue": "No", 
                "time_frame": "Up to 7 days"
            }, 
            {
                "measure": "Adverse effects", 
                "safety_issue": "Yes", 
                "time_frame": "Up to 7 days"
            }, 
            {
                "measure": "Number of liquid stools", 
                "safety_issue": "No", 
                "time_frame": "Up to seven days"
            }
        ], 
        "source": "Sinaloa Pediatric Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Sinaloa Pediatric Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "February 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}